Contrary to expectations, in SARDs with high adiponectin serum levels, such as RA, low levels of PPAR-γ expression or activity is present and also beneficial effects of PPAR-γ activation have been demonstrated [160,161]. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.